Biorepositories: Let's not lose what we have so carefully gathered!

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 599-601

  Goodman, Gary E ^a,b,c   Thornquist, Mark D ^a,b   Edelstein, Cim ^a   Omenn, Gilbert S ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; CONJUGATED ESTROGEN; DNA; FINASTERIDE; PROGESTERONE; RALOXIFENE; RNA; SELENOMETHIONINE; TAMOXIFEN;

BREAST CANCER; CANCER; CANCER MORTALITY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; DRUG MONITORING; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC RISK; HEALTH CARE COST; HUMAN; LUNG CANCER; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS;

BIOLOGICAL SPECIMEN BANKS; CLINICAL TRIALS; FEMALE; GENOMICS; HUMANS; MALE; NEOPLASMS; OWNERSHIP; PRESERVATION, BIOLOGICAL; UNITED STATES;

EID: 33646268664     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0873     Document Type: Note

References (16)

1. National Cancer Institute: Office of Biorepositories and Biospecimen Research [homepage on the internet]. Washington: U.S. National Institutes of Health; 2006 [cited 2006 Jan 19]. Available from: http://biospecimens.cancer.gov/.
2. Thornquist MD, Edelstein C, Goodman GE, Omenn GS. Streamlining IRB review in multisite trials through single-study IRB cooperative agreements: experience of the B-Carotene and Retinol Efficacy Trial (CARET). Control Clin Trials 2002;23:80-6.
3. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
4. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
5. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
6. Goodman GE, Thornquist MD, Balmes J, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004;96:1743-50.
7. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
8. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65.
9. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55.
10. Higgins B, Thompson IM. The Prostate Cancer Prevention Trial: current status. J Urol 2004;171:S15-7; discussion S8.
11. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
12. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
13. Martino S, Costantino J, McNabb M, et al. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Oncologist 2004;9:116-25.
14. Ford LG, Minasian LM, McCaskill-Stevens W, Pisano ED, Sullivan D, Smith RA. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003;53:82-101.
15. Vogel VG, Costantino JP, Wickerham DL, Cronin WM. National Surgical Adjuvant Breast and Bowel Project Update: prevention trials and endocrine therapy of ductal carcinoma in situ. Clin Cancer Res 2003;9:495-501s.
16. Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial. J Urol 2001;166:1311-5.